Although vernix caseosa is known to be a natural biofilm at birth, human pulmonary surfactant commences to remove the vernix from fetal skin into the amniotic fluid at gestational week 34, i.e., well before delivery. To explain this paradox, we first produced two types of fluorescently labeled liposomes displaying morphology similar to that of pulmonary surfactant and vernix caseosa complexes. We then continuously administered these liposomes into the amniotic fluid space of pregnant rabbits. In addition, we produced pulmonary surfactant and vernix caseosa complexes and administered them into the amniotic fluid space of pregnant rabbits. The intra-amniotic infused fluorescently labeled liposomes were absorbed into the fetal intestinal epithelium. However, the liposomes were not transported to the livers of fetal rabbits. We also revealed that continuous administration of micelles derived from pulmonary surfactants and vernix caseosa protected the small intestine of the rabbit fetus from damage due to surgical intervention. Our results indicate that pulmonary surfactant and vernix caseosa complexes in swallowed amniotic fluid might locally influence fetal intestinal enterocytes. Although the present studies are primarily observational and further studies are needed, our findings elucidate the physiological interactions among pulmonary, dermal-epidermal, and gastrointestinal developmental processes. micelle; intestinal epithelium; gastrointestinal development THE TURBIDITY OF AMNIOTIC fluid increases with gestational age during the third trimester (1, 2, 19, 21, 28) . Narendran et al. (19) speculated that pulmonary surfactant induces a "roll-up" phenomenon that leads to detachment of vernix caseosa from the fetal skin surface. We have emphasized the need to confirm that pulmonary surfactant micelles are indispensable to proving the hypothesis of Narendran et al. (19) because the roll-up phenomenon is strictly controlled by micellization process kinetics (13, 15). We previously revealed micelle particles in human amniotic fluid at term (20) . We also demonstrated that human pulmonary surfactant micelles induce detachment of vernix caseosa under in vitro conditions (20) .
THE TURBIDITY OF AMNIOTIC fluid increases with gestational age during the third trimester (1, 2, 19, 21, 28) . Narendran et al. (19) speculated that pulmonary surfactant induces a "roll-up" phenomenon that leads to detachment of vernix caseosa from the fetal skin surface. We have emphasized the need to confirm that pulmonary surfactant micelles are indispensable to proving the hypothesis of Narendran et al. (19) because the roll-up phenomenon is strictly controlled by micellization process kinetics (13, 15) . We previously revealed micelle particles in human amniotic fluid at term (20) . We also demonstrated that human pulmonary surfactant micelles induce detachment of vernix caseosa under in vitro conditions (20) .
Vernix caseosa is a complex, proteolipid material synthesized in part by fetal sebaceous glands during the last trimester of pregnancy (26) . The strategic location of vernix caseosa on the fetal skin surface suggests participation in multiple overlapping functions required at birth; for example, as a barrier to water loss, temperature regulation, and innate immunity (26) . This raises one important question. Since vernix caseosa is a natural biofilm at birth, why does vernix detachment from the fetal skin into the amniotic fluid commence at gestational week 34, i.e., well before delivery (1)? In an effort to explain this paradox, we endeavored to reveal the biological role of pulmonary surfactant and vernix caseosa in amniotic fluid. However, it is difficult to directly assess the kinetics of pulmonary surfactant and vernix caseosa in amniotic fluid. Therefore, we first produced two types of fluorescently labeled liposomes displaying morphology similar to that of pulmonary surfactant and vernix caseosa complexes (20) . We then continuously administered these liposomes into the amniotic fluid space of pregnant rabbits. In addition, we produced pulmonary surfactant and vernix caseosa complexes and administered them into the amniotic fluid space of pregnant rabbits.
MATERIALS AND METHODS
All procedures were performed in accordance with the University of Fukui Institutional Animal Care and Use Committee policy. The Institutional Review Board of the University of Fukui approved this study.
Experiments Using Two Types of Fluorescently Labeled Liposomes
Preparation of PKH26-labeled liposomes. Labeling of liposomes was performed by use of a PKH26 (excitation wavelength 551 nm, emission wavelength 567 nm) red fluorescent cell linker kit (SigmaAldrich, St. Louis, MO). We modified previously described methods (12) using a dried empty cationic liposomal formulation (Coatsome EL-01-C; NOF, Tokyo, Japan) consisting of dipalmitoyl-phosphatidylcholine-cholestero-stearyl amine (52:40:8) (10). Briefly, 4 ml of distilled water was added to 400 mg of Coatsome EL-01-C and then mixed with 16 l of 1 mmol/l PKH26. The mixture was agitated gently by slow rotation on a rotisserie/shaker (Labquake; Barnstead/ Thermolyne, Dubuque, IA). The PKH26-labeled liposomes were centrifuged at 100,000 g (Himac CS100GX microultracentrifuge) for 20 min to remove free PKH26. The sediments were dispersed with 4 ml of saline and subsequently filtrated via a 0.22-m filter unit (MILLEX-GV; Millipore, County Cork, Ireland). The PKH26-labeled liposomes were then compared with pulmonary surfactant micelles (Fig. 1) .
Preparation of liposomes containing BODIPY-labeled palmitic acid. Palmitic acid (C16:0) is the main saturated fatty acid component of vernix caseosa (11, 23) . Injection of fluorescently labeled fatty acid into liposomes was performed by using a BODIPY-labeled palmitic acid (excitation wavelength 503 nm, emission wavelength 512 nm): 4,4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacene-3-hexadecanoic acid (BODIPY-FL C 16; Life Technologies, Carlsbad, CA) and the Coatsome EL-01-C according to previously described methods (8, 10) . Briefly, the BODIPY-labeled palmitic acid solution was prepared by dissolving 2.0 mol of BODIPY-FL C 16 in 50 l of DMSO (Toray Fine Chemicals, Chiba, Japan) and diluting it to 10 ml with distilled water (8) . Then, 4 ml of 200 mol/l BODIPY-labeled palmitic acid solution was added to 400 mg of the Coatsome EL-01-C. The mixture was agitated by slow rotation on a rotisserie/shaker (Labquake). The liposomes containing BODIPY-FL C 16 were centrifuged at 100,000 g for 20 min to remove free BODIPY-FL C16. The sediments were dispersed with 4 ml of saline and subsequently filtrated using a 0.22-m filter unit (MILLEX-GV). BODIPY-FL C16 including palmitic acid allowed adequate comparison to vernix caseosa (Fig. 1) .
Electron microscopic analysis of fluorescently labeled liposomes. An aliquot (2 l) of each sample for electron microscopy was stained negatively using 2% phosphotungstic acid at pH 7.2 (5, 17) and analyzed within 1 h after sample preparation. Electron micrographs were viewed at 80 kV via a transmission electron microscope (H-7650; Hitachi High-Technologies, Tokyo, Japan).
Fluorescence microscopic analysis of fluorescently labeled liposomes. One milliliter of each sample for fluorescence microscopy was directly dispersed onto silanized slides (Dako Japan, Tokyo, Japan), and a coverslip was immediately placed on each slide. Each fluorescence image was visualized via an Olympus IX70 microscope (Olympus, Tokyo, Japan) with a green excitation filter for PKH26 and a blue excitation filter for BODIPY-FL C 16 Infusion study of fluorescently labeled liposomes. ANIMALS. Sixteen pregnant Japanese white rabbits weighing between 4.2 and 5.4 kg were obtained from a commercial rabbit breeder on day 22 of their normal 31-day gestation (3, 4) . The PKH26-labeled liposomes were intra-amniotically administered to eight rabbits, and liposomes containing BODIPY FL C 16 were administered to the other eight rabbits. We selected the ovarian-end fetuses of the gravid bicornate uterus as our experimental animal: study groups were the right-sided fetuses and control groups were the left-sided fetuses (Fig. 2) . On gestational day 25, miniosmotic pumps (Alzet model 2ML1, Durect, Cupertino, CA) were loaded with either 2 ml of fluorescently labeled liposomes or hydrated Coatsome EL-01-C alone. A 5-cm sterile PE 60 silicone catheter with an end silicone flange was attached to each pump.
OPERATIVE PROCEDURE. During the operative procedures, the rabbits were anesthetized with intravenous injections of pentobarbital sodium at a dose of 25.0 mg/kg body wt. In addition, 10 ml of local anesthetic (0.5% lidocaine) was injected into the surgical site before the operation began. A maternal midline laparotomy was made. The gravid bicornate uterus was exposed, and the ovarian-end fetuses were identified (Fig. 2) . Right-sided ovarian-end fetuses received the fluorescently labeled liposomes; left-sided fetuses received hydrated Coatsome EL-01-C alone. A 5-0 Vicryl purse-string suture was placed through the antimesenteric border of the uterine wall, including fetal membranes. The flange was placed in the amniotic cavity. The purse string was secured, and the laparotomy was closed in two layers with Vicryl suture.
On gestational day 29, does were given anesthesia identical to that used for the initial laparotomy. The original incision was opened and the uterus was exposed. Catheter placement and pump function were verified by ensuring near evacuation of each solution. Fetuses were removed and the maternal rabbit was given a lethal dose of pentobarbital sodium. After recording of the somatic weight, each fetus was euthanized by cervical dislocation. Fetal small intestines and livers were removed and washed in phosphate-buffered saline.
FROZEN SECTIONS. Each fetal organ was immediately snap frozen on dry ice and embedded with optimum cutting temperature compound (Tissue-Tek O.C.T Compound; Sakura Finetechnical, Tokyo, Japan). After incubation at Ϫ80°C, 10-m-thick frozen sections were prepared on a Leica CM 3050 cryostat (Leica Microsystems, Wetzlar, Germany). The sections were mounted in VECTASHIELD containing 4=,6-diamidine-2=-phenylindole dihydrochloride [VECTASHIELD Hard·Set Mounting Medium with 4,6-diamidino-2-phenylindole (DAPI); Vector Laboratories, Burlingame, CA]. Stained sections were visualized via an Olympus IX70 microscope with a green excitation filter for PKH26, a blue excitation filter for BODIPY-FL C16, and an ultravi- olet excitation filter for DAPI. The images were analyzed using computer software (DP Controller and DP Manager).
Experiments Using Vernix Caseosa-Surfactant TA Mixture
Preparation of vernix caseosa-surfactant TA mixture. Samples were prepared according to the procedure of Narendran et al. (19) . The composition of surfactant TA (Surfacten; Mitsubishi Tanabe Pharma, Osaka, Japan), which is isolated from bovine lung and used clinically (7) , is similar to that of Survanta (Ross Laboratories). Its composition is 83.5% phospholipids, 7.0% free fatty acids, 7.0% triglycerides, 1.0% hydrophobic surfactant-associated protein, and traces of other components (25) . Briefly, vernix caseosa was harvested from full-term infants free of antenatal complications and was stored in sterile vials at the time of delivery. Samples were refrigerated at Ϫ80°C until the experiments. We applied 10 mg of vernix caseosa pooled from three full-term infants to the interior walls of 1.5-ml polypropylene microfuge tubes and spread it onto the wall using a glass pestle to form an even coating. Then, 1 ml of normal saline with 1,180 g phospholipid derived from surfactant TA was added to the tubes. The dose of surfactant TA was calculated from the amniotic fluid volume of pregnant rabbits at gestational day 30 (0.72 ml) (14) , total lipid concentrations in human amniotic fluid at term (386 g) (16) , and the infusion volume of miniosmotic pumps (240 l/day). The mixture was agitated gently by slow rotation on a rotisserie/ shaker (Labquake; Barnstead/Thermolyne). The rotisserie was placed overnight in a thermally equilibrated room at 37°C. The liquid was decanted and subsequently used for the intra-amniotic infusion study.
Infusion study of vernix caseosa-surfactant TA mixture. ANIMALS. Eighteen pregnant Japanese white rabbits weighing between 3.1 and 4.2 kg were obtained from a commercial rabbit breeder on day 20 of their normal 31-day gestation (3, 4) . The vernix caseosa-surfactant TA mixtures were intra-amniotically administered to each rabbit.
OPERATIVE PROCEDURE. Operative procedures were similar to those described above. Briefly, on gestational day 23, miniosmotic pumps were loaded with either 2 ml of the vernix caseosa-surfactant TA mixtures or normal saline. A 5-cm sterile PE 60 silicone catheter with an end silicone flange was attached to each pump. Right-sided ovarian-end fetuses received the vernix caseosa-surfactant TA mixtures; left-sided fetuses received normal saline. On gestational day 29, does were given anesthesia identical to that used for the initial laparotomy. Fetuses were removed and the maternal rabbit was given a lethal dose of pentobarbital sodium. Each fetus was euthanized by cervical dislocation. Fetal small intestines were removed and washed in phosphate-buffered saline. In addition, two nonsurgical interventional pregnant rabbits were cesarean sectioned on gestational day 29 to confirm normal fetal villus height. Ten noninterventional fetuses on gestational day 29 were removed and their small intestines were resected and washed in phosphate-buffered saline.
HISTOLOGICAL EXAMINATION. Two samples (each 3 cm) of each intestinal tissue were removed at sites along the entire length of the small intestine. The first samples were taken at a site located one-third of the length of the small intestine distal to the stomach (proximal intestinal samples). The second samples were taken at a site located one-third of the length of the small intestine prior to the appendix (distal intestinal samples). The samples used in these analyses were gradually dehydrated in an ethanol series (50% to 100%), embedded in paraffin, sectioned at 3 m, and stained with hematoxylin and eosin. Three parts containing at least six complete longitudinal sections of a villus and its associated crypt were selected for each sample and were viewed at ϫ40 magnification via an Olympus AX-80 light microscope. Images were digitally captured for later analysis using Mac SCOPE (Mitani, Fukui, Japan). The villus heights were determined according to the procedure described by Hampson (9) . To reduce measurement variability, villus heights were measured by the same person (Mari Ito). The height of the villus was measured from the tip to the crypt-villus junction. At least 18 villi were measured in each sample.
Statistical Analysis
Data are expressed as means Ϯ standard deviation. Statistical analyses were performed using StatView software, version 5.0 (SAS Institute, Cary, NC). Student's t-test was used for continuous variables. All statistical tests were two sided and significance was defined as P Ͻ 0.05. 
RESULTS

Experiments Using Two Types of Fluorescently Labeled Liposomes
Electron microscopic analysis of fluorescently labeled liposomes. Transmission electron microscopy revealed lamellar liposomes to be spherical and uniformly dispersed with mean diameters ranging from 30 to 90 nm (Fig. 3) . The average diameters of PKH26-labeled liposomes, BODIPY-FL C 16 liposomes, and empty liposomes were 39.8, 44.6, and 41.4 nm, respectively. Empty liposomal formulations exhibited similar morphologies showing neither aggregation nor fusion, such that the fluorescent labeling procedure might not affect the physicochemical properties of liposomes, e.g., liposomal morphology, dispersibility, and stability (Fig. 3 ). There were no significant changes in liposomal morphology during an observation period of at least 7 days (data not shown).
Fluorescence microscopic analysis of fluorescently labeled liposomes. Fluorescence microscopy revealed fluorescently labeled liposomes to be homogeneously dispersed and high fluorescence intensities were visualized (Fig. 4) .
Intra-amniotic infusion of fluorescently labeled liposomes. There were no maternal mortalities, but two preterm deliveries and three intrauterine fetal demises occurred. Twenty-two of 32 total fetuses survived the entire study period for an overall fetal survival rate of 68.8%. Fetal somatic weights, liver Fig. 2A ). C: micrograph of empty liposomes. The average diameters of 2 types of fluorescently labeled liposomes did not differ significantly from that of empty liposomes (P Ͼ 0.05). They also exhibit similar morphologies, showing neither aggregation nor fusion, suggesting that the fluorescence-labeling procedure does not affect the physicochemical properties of liposomes, e.g., liposomal morphology, dispersibility, and stability (see A and B). Calibration bar: 100 nm (original magnification: ϫ200,000). weights, and small intestinal length are presented in Table 1 . There were no differences in fetal somatic weights, liver weights, or small intestinal length between the fluorescent liposome infusion group and controls ( Table 1 ). The fetal small intestinal epithelia were stained with PKH26 and BODIPY-FL C 16 (Fig. 5) . However, no fluorescently labeled liposomes reached the fetal livers (Fig. 5) .
Experiments Using Vernix Caseosa-Surfactant TA Mixture
Intra-amniotic infusion of vernix caseosa-surfactant TA mixture. There were no maternal mortalities, but six preterm deliveries and five intrauterine fetal demises occurred. Fourteen of the 36 total fetuses survived the entire study period for an overall fetal survival rate of 38.9%. There were no differences in fetal somatic weights or small intestinal length between the vernix caseosa-surfactant TA infusion group and controls. The villus height of the proximal intestine in the study and control groups were 285.8 Ϯ 103.5 (mean Ϯ SD) and 202.2 Ϯ 82.4 m, respectively (P Ͻ 0.05). The distal intestinal villus height was greater in the study [257.4 Ϯ 77.1 (mean Ϯ SD) m] than in the control (184.3 Ϯ 87.3 m) group (P Ͻ 0.05) (Fig. 6) . The nonsurgical fetal villus heights of the proximal and distal intestines were 331.8 Ϯ 76.7 (mean Ϯ SD) m and 292.4 Ϯ 73.5 m, respectively. These villus heights were significantly greater than those of the vernix caseosasurfactant TA infusion group and the normal saline infusion group (P Ͻ 0.05).
DISCUSSION
To our knowledge, this is the first investigation of the role of pulmonary surfactant and vernix caseosa complexes in the amniotic fluid of term pregnancies. The major finding of our study is that continuous administration of micelles derived from pulmonary surfactants and vernix caseosa protected the small intestine of the rabbit fetus from damage due to surgical intervention. We also demonstrated that intra-amniotically infused fluorescently labeled liposomes were absorbed into the fetal intestinal epithelium. However, these liposomes were not transported to the livers of fetal rabbits.
We created two types of fluorescently labeled liposomes displaying morphology similar to that of the micelles of pulmonary surfactant and vernix caseosa: PKH26-labeled liposomes and BODIPY-FL C 16 liposomes. We previously showed the average diameter of micelles derived from surfactant TA to be 35.4 nm (20) . The average diameter of micelles derived from the vernix caseosa and surfactant TA mixtures is reportedly 46.8 nm (20) . These average diameters did not differ significantly from the average diameter of PKH26-labeled liposomes and BODIPY-FL C 16 liposomes (P Ͼ 0.05). Negative staining methods suggest that our fluorescently labeled liposomes might exhibit physicochemical properties similar to those of micelles of pulmonary surfactant and vernix caseosa under in vitro conditions. Our studies also raise the possibility that human fetuses might also swallow pulmonary surfactant and vernix caseosa in amniotic fluid, which could then reach the fetal small intestines.
Our surgical intervention interfered with villus growth and submucosal thickness of the small intestine in the rabbit fetus. Intra-amniotically infused pulmonary surfactants and vernix caseosa protected the small intestine of the rabbit fetus from surgical damage. We speculate that this phenomenon is the key to solving the aforementioned paradox. The multiple functions of pulmonary surfactant have been reassessed in light of recent studies (27) . The fetal lung synthesizes and excretes much greater amounts of pulmonary surfactant than are needed for adaptation to breathing air after birth. Ran-Ressler et al. (22) also presented that vernix caseosa is actively metabolized in the fetal gastrointestinal tract. The present studies suggest that pulmonary surfactant and vernix caseosa complexes in swallowed amniotic fluid might influence fetal enterocytes.
Our present studies have limitations. First, there are several differences between pulmonary surfactant and PKH26-labeled liposomes and between vernix caseosa and BODIPY-labeled palmitic acid. Pulmonary surfactant and vernix caseosa are not the sole substance and differ in composition from PKH26-labeled liposomes and BODIPY-labeled palmitic acid. We recognize that it is difficult to directly demonstrate the kinetics of pulmonary surfactant and vernix caseosa intra-amniotically infused into pregnant rabbits. Therefore, we had to use PKH26-labeled liposomes instead of pulmonary surfactant in our fluorescent liposome experiments, because both pulmonary surfactant and liposomes contain considerable quantities of dipalmitoyl-phosphatidylcholine (10, 16) . We also used BODIPY-FL C 16 instead of vernix caseosa, because palmitic acid is the main saturated fatty acid component of vernix caseosa (11, 23) . Vernix caseosa still contains shed keratinocytes whereas the BODIPYlabeled palmitic acid is comprised solely of lipids. Regarding this point, we speculate that pulmonary surfactant cannot contain keratinocytes of vernix caseosa in human term amniotic fluid, on the basis of the average diameter of micelles derived from pulmonary surfactant (20) . In our experiment, to create a more physiological setting, we used BODIPY-FL C 16 instead of palmitic acid in vernix caseosa.
Second, we did not consider the influence of endogenous surfactant/vernix on our experimental results. Although fetal rabbits have endogenous surfactant, they start to produce pulmonary surfactant after gestational day 28 (6) . Intraamniotic infusions of fluorescently labeled liposomes were performed on pregnant rabbits from gestational days 25 to 29 of their normal 31-day gestation (fluorescent liposome experiments). The vernix caseosa-surfactant TA mixtures were intra-amniotically administered to pregnant rabbits from gestational days 23 to 29 (vernix caseosa-surfactant TA experiments). We believe that the influence of endogenous surfactant/vernix on our experimental model was negligible.
Third, we did not consider the dose-response for the micelles. We used two types of fluorescently labeled liposomes, in excessive doses compared with the lipid concentrations in human amniotic fluid at term (16) . We consider it to be important that even these excess fluorescently labeled liposomes could not be transported to the livers of fetal rabbits.
Our studies raise the possibilities regarding the kinetics of micelle particles in human amniotic fluid. Micellization is an important step in postnatal lipid absorption because fat is insoluble in the aqueous environment of the small-intestinal lumen (2, 18) . Micelles exist in both amniotic fluid swallowed by the fetus and human breast milk ingested by neonates (2, 19, 20) . Numerous studies have also shown that maturation of the fetal gastrointestinal tract is partially enhanced by swallowed amniotic fluid (2, 24) . Our results indicate that micelles derived from pulmonary surfactant and vernix caseosa in swallowed amniotic fluid might directly and locally influence fetal intestinal enterocytes. Although the present study is primarily observational and further studies are needed, our findings shed light on the physiological interactions among pulmonary, dermal-epidermal, and gastrointestinal developmental processes.
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